Paragon Therapeutics, Inc.
Records under this name other than the patents Paragon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Back to Paragon Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 18/917,838 | FCRN Antagonists with Improved Half-Life and Methods of Use Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/069,168 | FC Fragments That Bind FCRN and Methods of Use Abandoned Abandoned Jan 9, 2026 | Abandoned | Abandoned Jan 9, 2026 | |
| 19/157,017 | Antibodies That Bind Interleukin 4 Receptor Alpha and Methods of Use held by Apogee Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/297,947 | FC Fragments That Bind FCRN and Methods of Use Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/302,809 | Long Acting ALPHA4BETA7 Targeting Molecule Compositions for the Treatment Gastrointestinal Inflammatory Disease Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/324,344 | IL-17 Binding Proteins, Compositions, and Methods of Use Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/355,961 | Albumin Binding Proteins and Methods of Use Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/376,465 | TL1A Binding Proteins and Methods of Use Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/393,395 | Long Acting ALPHA4BETA7 Targeting Molecule Compositions for the Treatment Gastrointestinal Inflammatory Disease Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/406,490 | TL1A Binding Proteins and Methods of Use Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |